Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
A fully integrated, end to end platform that enables real time situation and work force management, for the private security industry. It ensures regulatory compliance and real time reporting for security operatives. FalconDHQ is addressing a gap in the market to modernise the current paper based process.
days to go:
Expired
investment:
£415,000
Ziglu is a financial technology entity that allows a user to access both Forex and digital currencies seamlessly. The company permits a user to use any currency via its Mastercard debit card and protects the user's digital currency up to £50,000 against cyber-attacks. Ziglu is authorised by the UK's Financial Conduct Authority (FCA) as an Electronic Money Institution (EMI) and is one of the first companies involved with digital currencies to be registered under the UK’s Anti-Money Laundering Regulations (AMLR). The company has achieved a 94% rating on TrustPilot, offers customers the option to send money via cryptocurrency, and previously raised £5.25 million in seed funding. Ziglu has featured in media entities like Coindesk and Yahoo Finance. It will use 30% of the investment in product development, 60% on user acquisition, and 10% on international expansion initiatives.
days to go:
Expired
investment:
£3,041,878
Whitehall Finance (WF) is a Business-to-Business (B2B) financial technology platform that provides working capital to UK-based Small and Medium Enterprises (SMEs). The company offers revolving credit facility that is withdrawable in currencies like GBP, USD or EURO or a combination of the above under a single facility agreement. It also permits buying companies to offer their suppliers an early payment for a discount, as well as, enables users to access Forex services and creditworthiness data of companies. WF has extended around £16 million in finance through 1,600+ transactions over its platform in the past one year. The company will use 30% of the investment to expand its sales, 20% to increase its marketing budget, 30% to increase operational capacity to service volume business, and 20% to develop key partner relationships.
days to go:
Expired
investment:
£160,027
Verto Homes have created the Zero Carbon Smart Home. These homes create and store their own clean energy from the sun, they automatically know when and where light heat and shade are needed and they manage the energy they use so efficiently that their energy bills are almost 0.
days to go:
Expired
investment:
£1,389,280
Tribal Sports Nutrition (TSN) uses the revitalising properties of the Baobab fruit to create energy smoothies. TSN claims that its smoothies are less concentrated than other sports nutrition brands, are 100% organic, and easy on the stomach. The company also incorporates vitamin C, antioxidants, fibre, and electrolytes into the smoothies to make it the on-the-go snack for active lifestyle consumers. TSN asserts that its baobab ingredient is wild-harvested by cooperatives in Africa, bringing income to people and preserving the local ecology. The company received a certification from the Organic Food Federation (OFF) and aims to achieve B Corp status. TSN's products have been listed in Sainsbury's and on Amazon. It will use the investment to double its existing product offering in 2021 and launch hydration, plant protein recovery products, and Baobab energy snacks.
days to go:
Expired
investment:
£421,647
Thyngs is a touch-free instant payment platform for businesses and charities. It has around 20 active re-seller partners for new sectors and markets. The company is working with PricewaterhouseCoopers (PwC) as part of its raise programme and actively engaging with several Series A Venture Capitalist (VC) funds intending to raise £4-5 million in late 2021 to scale its business. Thyngs aggregates various payment partners including PayPal, Worldpay, Apple Pay and Google Pay. The company was the cashless donation platform for 210,000 fundraising events for Macmillan's 'World's Biggest Coffee Morning', which raised £27 million in 2019. Many reputed organisations such as Warner Bros, Royal British Legion, Wasabi, National Geographic, and ANZ Bank are working with Thyngs. The company will use the investment to enhance its marketing campaign, bolster its sales team, work on data security and integrations on its platform, and expand the account management team to boost its business.
days to go:
Expired
investment:
£329,591
